BioClinica Launches Educational Webinar Series

BioClinica™, Inc. (NASDAQ: BIOC), a global provider of clinical trial management services, announced a series of new industry webinars, offering information to clinical trial sponsors and insight into the latest industry trends, clinical management resources and industry best practices. Webinars will be led by key company experts on Wednesdays beginning October 27, 2010. The schedule will begin with a trio of presentations focused on Clinical Trial Management Systems that illustrate essential considerations and new strategies for managing clinical trials.

October

Clinical Trial Management and SharePoint
October 27, 2010; 2:00pm – 3:00pm (Eastern Time)

SharePoint’s flexibility and manageability are changing the clinical application landscape. Jeremiah Rehm, Clinical Solutions Specialist at BioClinica, will discuss the tremendous opportunities that SharePoint offers for clinical operations and for the IT staff that supports them. He will illustrate how to maximize SharePoint’s capabilities by freeing clinical data from application silos while meeting regulatory requirements for clinical trials.

November

Confusion in the Market: What’s New in the CTMS Industry?
November 3, 2010; 2:00pm – 3:00pm (Eastern Time)

Robert Webber, VP of Clinical Trial Management Systems (CTMS) at BioClinica will examine the evolution of CTMS and why there is so much confusion in the marketplace about CTMS today. Trial managers and staff will learn key considerations for the evaluation and selection of a new or replacement CTMS and gain insight into the practical value of an ‘open system’ architecture.

December

The Bottom Line on Managing Clinical Site Payments
December 1, 2010; 2:00pm – 3:00pm (Eastern Time)

Clinical Solutions Specialist Jeremiah Rehm at BioClinica asks the question, "Why manage your own site payments?” He’ll tackle the tough issues surrounding regulatory requirements, speed, and cost savings, discussing challenges and new strategies for handling them with improved efficiency.

BioClinica’s CTMS solutions help clients to better manage clinical trials by improving the planning and tracking of the complex logistics frequently associated with these projects. BioClinica CTMS leverages the ubiquity of Microsoft Office and the power of Microsoft SharePoint for maximum control with manageability. Jim Dorsey, Vice President of Marketing for BioClinica said, "These webinars will provide insight and guidance to clinical trial sponsors about the latest trends in the marketplace. As a leader in the CTMS industry, our staff is well-versed in the issues and challenges facing the industry, and the solutions that are available.”

To register for the webinars, please visit: http://www.bioclinica.com/webinars.

Follow BioClinica on the Trial Blazers blog at http://info.bioclinica.com/blog, and on twitter at http://twitter.com/bioclinica.

About BioClinica, Inc.

BioClinica, Inc. is a leading global provider of integrated, technology-enhanced clinical trial management services. BioClinica supports pharmaceutical and medical device innovation with imaging core lab, internet image transport, electronic data capture, interactive voice and web response, clinical trial management and clinical supply chain design and optimization solutions. BioClinica services maximize efficiency and manageability throughout all phases of the clinical trial process. With more than 20 years of experience and over 2,000 successful trials to date, BioClinica has supported the clinical development of many new medicines from early phase trials through final approval. BioClinica operates state-of-the-art, regulatory-body-compliant imaging core labs on two continents, and supports worldwide eClinical and data management services from offices in the United States, Europe and Asia. For more information, please visit www.bioclinica.com.

Certain matters discussed in this press release are "forward-looking statements” intended to qualify for the safe harbors from liability established by the Private Securities Litigation Reform Act of 1995. In particular, the Company’s statements regarding trends in the marketplace and potential future results are examples of such forward-looking statements. The forward-looking statements include risks and uncertainties, including, but not limited to, the consummation and the successful integration of current and proposed acquisitions, the timing of projects due to the variability in size, scope and duration of projects, estimates and guidance made by management with respect to the Company’s financial results, backlog, critical accounting policies, regulatory delays, clinical study results which lead to reductions or cancellations of projects, and other factors, including general economic conditions and regulatory developments, not within the Company’s control. The factors discussed herein and expressed from time to time in the Company’s filings with the Securities and Exchange Commission could cause actual results and developments to be materially different from those expressed in or implied by such statements. The forward-looking statements are made only as of the date of this press release and the Company undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstance. You should review the Company’s filings, especially risk factors contained in the Form 10-K and the recent Form 10-Q.